标题：
Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof
授权日：
2015-02-10
公开(公告)号：
US8951742
申请日：
2009-02-02
公开(公告)日：
2015-02-10
当前申请(专利权)人：
MEDIZINISCHE HOCHSCHULE HANNOVER
发明人：
WOLLERT, KAI C. | KEMPF, TIBOR | WALLENTIN, LARS | DREXLER, HELMUT
简单同族：
AT511656T | AU2007280413A1 | AU2007280413B2 | BRPI0715126A2 | BRPI0715126B1 | CA2660691A1 | CA2660691C | CN106018820A | CN106018820B | EP2047275A2 | EP2047275B1 | EP2315034A2 | EP2315034A3 | HK1136627A1 | HK1229887A | HK1229887A1 | JP2009545735A | JP5309026B2 | KR101245877B1 | KR1020090047451A | MX2009000914A | SG149375A1 | US20110065204A1 | US20150362511A1 | US20200081020A1 | US8951742 | WO2008015254A2 | WO2008015254A3
简单同族成员数量：
28
简单同族被引用专利总数：
90
诉讼案件数：
0
法律状态/事件：
授权 | 权利转移